valproic acid has been researched along with Berger Disease in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Q | 1 |
| Liu, J | 1 |
| Du, YL | 1 |
| Hao, X | 1 |
| Ying, J | 1 |
| Tan, Y | 1 |
| He, LQ | 1 |
| Wang, WM | 1 |
| Chen, N | 1 |
1 other study available for valproic acid and Berger Disease
| Article | Year |
|---|---|
Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.
Topics: Cell Proliferation; Cells, Cultured; Extracellular Matrix; Glomerulonephritis, IGA; Histone Deacetyl | 2016 |